A viral claim vs. the evidence: what the 2002 onion juice trial does (and doesn't) show

A tweet circulating now (https://x.com/jamesbondwisdom/status/2074546487480950807) claims raw onion juice gives "87% regrowth in 6 weeks," via sulfur→keratin/collagen, glutathione, quercetin blocking 5-alpha-reductase (DHT), and minoxidil-like vasodilation — calling it "the most effective natural hair regrowth treatment ever documented."

The number is real; the interpretation isn't well supported.

The actual source: Sharquie & Al-Obaidi, J Dermatol 2002 (doi:10.1111/j.1346-8138.2002.tb00277.x; PMID 12126069). This study was designed to test the effectiveness of topical crude onion juice in the treatment of patchy alopecia areata in comparison with tap water. At six weeks, hair re-growth was observed in 20 patients (86.9%) versus 2 patients (13%) in the tap-water control group (P<0.0001) — so the figure checks out.

Gap 1 — wrong condition. Alopecia areata is an autoimmune, patchy condition; androgenetic alopecia (what the tweet implies via DHT talk) is a distinct, androgen-driven process. A 2019 review is explicit that these findings do not apply to androgenetic alopecia—male and female pattern baldness—which affects far more people. No AGA patients were ever enrolled.

Gap 2 — invented mechanism. The original authors said "the mechanism of action of crude onion juice... is difficult to explain," proposing antigenic competition or irritant contact dermatitis instead — consistent with 60.8% of completers developing mild scalp reddening. Meanwhile the tweet's specific DHT claim doesn't hold: quercetin inhibits 5-alpha-reductase in a cell-free tube but loses that activity in whole cells. Quercetin does show benefit in an alopecia areata mouse model via immune modulation — a different story than "blocks DHT."

Gap 3 — quality/replication. A systematic review assigned the trial a quality rating of two out of five, and the treatment arm had a 48.9% dropout rate vs. 11.8% in controls, with blinding impossible due to smell. Twenty-three years on, it appears in no major dermatology guideline, and a Cochrane review concluded there is "no reliable, safe, effective, long-term treatment" for alopecia areata at all.

Open questions: Has anyone tested onion-derived sulfur compounds/quercetin directly in AGA/dermal-papilla models rather than the AA context this trial used? Given the irritant hypothesis, would any comparably irritating topical reproduce this effect in AA — i.e., is it compound-specific or reaction-specific? Would a modern RCT with objective hair counts replicate anywhere near 87%, or regress toward typical alternative-remedy effect sizes?

References

1. Sharquie KE, Al-Obaidi HK. Onion Juice (Allium cepa L.), A New Topical Treatment for Alopecia Areata. J Dermatol. 2002;29(6):343-346. doi:10.1111/j.1346-8138.2002.tb00277.x. PMID: 12126069.
2. Hosking AM, Juhász M, Atanaskova Mesinkovska N. Complementary and Alternative Treatments for Alopecia: A Comprehensive Review. Skin Appendage Disord. 2019;5(2):72-89.
3. Azizi A, Mumin NH, Shafqat N. Phytochemicals With Anti 5-alpha-reductase Activity. F1000Research 2021;10:221. doi:10.12688/f1000research.51066.3. PMID: 34316358.
4. Wikramanayake TC, et al. Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell Stress Chaperones. 2012;17(2):267-274. doi:10.1007/s12192-011-0305-3.
5. Sladden MJ, et al. Cochrane review of alopecia areata interventions, summarized in "Studies Don't Support Common Treatments For Patchy Hair Loss," ScienceDaily, 2008.
6. Source claim: X post, @jamesbondwisdom, https://x.com/jamesbondwisdom/status/2074546487480950807